On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Ralf‐Dieter Hofheinz

ResearcherPublications, citations & collaboration network

Ralf‐Dieter Hofheinz is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Ralf‐Dieter Hofheinz have?

ScholarIQindexed works

Ralf‐Dieter Hofheinz has 624 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Ralf‐Dieter Hofheinz have?

ScholarIQcitation count

Ralf‐Dieter Hofheinz has 19,421 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Ralf‐Dieter Hofheinz?

ScholarIQh-index

Ralf‐Dieter Hofheinz has an h-index of 58 in OpenAlex.

What is the i10-index of Ralf‐Dieter Hofheinz?

ScholarIQi10-index

Ralf‐Dieter Hofheinz has an i10-index of 210 in OpenAlex.

What is the ORCID of Ralf‐Dieter Hofheinz?

ScholarIQorcid

The ORCID for Ralf‐Dieter Hofheinz is on the source record.

What is the OpenAlex record for Ralf‐Dieter Hofheinz?

ScholarIQopenalex

The OpenAlex for Ralf‐Dieter Hofheinz is on the source record.

What are the most-cited papers on Ralf‐Dieter Hofheinz?

ScholarIQmost cited works
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial
Salah‐Eddin Al‐Batran, Ralf‐Dieter Hofheinz, Claudia Pauligk, Hans‐Georg Kopp, Georg Martin Haag, Kim Barbara Luley, Johannes Meiler, Nils Homann, Sylvie Lorenzen, Harald Schmalenberg, Stephan Probst, Michael Koenigsmann, Matthias Egger, Nicole Prasnikar, Karel Caca, Jörg Trojan, Uwe M. Martens, Andreas Block, Wolfgang Fischbach, Rolf Mahlberg, Michael Clemens, Gerald Illerhaus, Katja Zirlik, Dirk Behringer, Wolff Schmiegel, Michael Pohl, Michael Heike, Ulrich Ronellenfitsch, Martin Schüler, Wolf O. Bechstein, Alfred Königsrainer, Timo Gaiser, Peter Schirmacher, Wael Hozaeel, Alexander Reichart, Thorsten Oliver Goetze, Mark Sievert, Elke Jäger, Stefan Mönig, Andrea Tannapfel
The Lancet Oncology. 2016742 Citations
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
Emmanouil Fokas, Michael Allgäuer, Bülent Polat, Günther Klautke, Gerhard G. Grabenbauer, Rainer Fietkau, Thomas Kuhnt, Ludger Staib, Thomas Brunner, Anca‐Ligia Grosu, Wolff Schmiegel, Lutz Jacobasch, Jürgen Weitz, Gunnar Folprecht, Anke Schlenska‐Lange, Michael Flentje, Christoph‐Thomas Germer, Robert Grützmann, Matthias Schwarzbach, Vittorio Paolucci, Wolf O. Bechstein, Tim Friede, Michael Ghadimi, Ralf‐Dieter Hofheinz, Claus Rödel, on behalf of the German Rectal Cancer Study Group
Journal of Clinical Oncology. 2019549 CitationsOPEN ACCESS
Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial
Ralf‐Dieter Hofheinz, Frederik Wenz, Stefan Post, Axel Matzdorff, Stephan Laechelt, Jörg T. Hartmann, Lothar Müller, Hartmut Link, Markus Moehler, E. Kettner, Elisabeth Fritz, U. Hieber, Hans Walter Lindemann, Martina Grunewald, Stephan Kremers, Christian Constantin, Matthias Hipp, G. Hartung, Deniz Gencer, Peter Kienle, Iris Burkholder, Andreas Hochhaus
The Lancet Oncology. 2012508 Citations
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
Emmanouil Fokas, Anke Schlenska‐Lange, Bülent Polat, Günther Klautke, Gerhard G. Grabenbauer, Rainer Fietkau, Thomas Kuhnt, Ludger Staib, Thomas Brunner, Anca‐Ligia Grosu, Simon Kirste, Lutz Jacobasch, Michael Allgäuer, Michael Flentje, Christoph‐Thomas Germer, Robert Grützmann, Guido Hildebrandt, Matthias Schwarzbach, Wolf O. Bechstein, Heiko Sülberg, Tim Friede, Jochen Gaedcke, Michael Ghadimi, Ralf‐Dieter Hofheinz, Claus Rödel, German Rectal Cancer Study Group, Detlef Imhoff, Guido Woeste, Nils Habbe, Ursula Pession, Martin‐Leo Hansmann, Peter J. Wild, Stephan Falk, Petra Hödl, A Serebrennikov, Sanja Schmeck, Vittorio Paolucci, Stephan Sahm, Martin Eichel, Giovanna Römer, W. Bank, Nicolas Moosmann, Jan Braess, P. Piso, Heinrich Wiesinger, Peter Kappl, Elisabeth Germer, Monika Warmuth‐Metz, Volker Kunzmann, Katica Krajinovic, Andreas Rosenwald, Thorsten Alexander Bley, Ulrich Stölzel, Manfred Dörne, L. Renziehausen, Joachim Boese-Land, Dietrich Meißner, D. Burchert, Olaf Dirsch, Jörg Olaf Habeck, Klaus Kirchhof, Christof Lamberti, B. J. Leibl, Andreas Gschwendtner, Godehard Lahmer, Marga Lang-Welzenbach, Werner Hohenberger, Thomas Kuhnt, Kirsten Papsdorf, Christian Wittekind, Christine Volkheimer, Frederik Wenz, Kirsten Merx, Stefan Post, Timo Gaiser, Ulrike Attenberger, Michael Geißler, Jörn Sträter, Helmut Gnann, Stefan Krämer, Michael Henke, Henning Schäfer, Philipp Manegold, Hannes Neeff, Peter Bronsert, Wolff Schmiegel, Michael Pohl, Christian Möllecken, Irenäus A. Adamietz, Richard Viehbahn, Andrea Tannapfel, Jens Freiberg‐Richter, Thorsten Jacobi, Wolfgang Wendt, Klaus Holzweißig, Thomas Kittner, Ullrich Graeven, Christiane Lange, U. Kania, Elisabeth Rösler
JAMA Oncology. 2021366 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account